Industry Research Reports

Home > Reports > Chemical & Material > Mefloquine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Mefloquine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-05-25

Pages: 144 Pages

Report ld: 4745699

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Mefloquine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Mefloquine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Mefloquine, a 4-quinolinemethanol compound, is an important antimalarial drug. It inhibits the growth of Plasmodium by disrupting mitochondrial function and DNA replication. With broad antimalarial activity against various Plasmodium species, including P. falciparum and P. vivax, it is well-absorbed orally, has a long half-life, and offers enduring efficacy. For prevention, weekly dosing suffices, while treatment requires only a short course. Widely used in malaria-endemic areas, it is especially valuable for chloroquine-resistant Plasmodium infections. It can also be combined with other antimalarials to enhance efficacy and delay resistance. However, mefloquine use is restricted due to potential severe neurological side effects like dizziness, insomnia, and anxiety, and rare but serious reactions such as psychiatric changes or arrhythmias. Risk-benefit evaluation and strict adherence to medical advice are essential for safe use.

Market Development Opportunities & Main Driving Factors

Mefloquine market growth is driven by malaria prevalence and rising drug resistance. In malaria-endemic regions like Africa and Southeast Asia, increasing chloroquine resistance boosts mefloquine demand as an alternative. Climate change and population movements are expanding malaria’s reach, further driving mefloquine need. Its preventive advantages make it a top choice for travelers and military personnel heading to high-risk malaria areas. Recent studies suggest mefloquine’s potential for greater role in combination therapies, creating new market opportunities. Also, public health policies in many countries support mefloquine use to combat malaria.

Market Challenges, Risks, & Restraints

Yet, the mefloquine market faces challenges. Its side effects, particularly severe neurological and psychiatric reactions, have led to stringent usage restrictions by many drug regulators, limiting demand. Also, it competes with multiple antimalarials like artemisinin-based combinations, each with their efficacy and safety advantages. Mefloquine must enhance cost-effectiveness and market recognition. Its complex production process, requiring advanced technology and equipment, raises costs and market entry barriers. Finally, growing Plasmodium resistance to mefloquine threatens its long-term competitiveness.

Downstream Demand Trends

For downstream demand, malaria treatment and prevention are the main mefloquine application fields. In treatment, rising Plasmodium resistance to traditional drugs keeps mefloquine relevant as a second-line therapy, especially in high-burden African and Southeast Asian regions. In prevention, rising international travel and business activities increase the number of people visiting malaria-endemic areas, providing steady growth for mefloquine’s preventive use. In the military sector, it remains crucial for protecting troops in high-risk areas. However, awareness of its side effects may reduce its preventive market share, confining its future use to tolerant specific groups. New antimalarials and vaccines could also squeeze its market share, but mefloquine will retain irreplaceability in certain regions and groups.

This report aims to provide a comprehensive presentation of the global market for Mefloquine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mefloquine by region & country, by Type, and by Application.

The Mefloquine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mefloquine.

MARKET SEGMENTATION

By Company

Toronto Research Chemicals
Alfa Chemistry
Waterstone Technology
2A PharmaChem
3B Scientific
Chembest Research Laboratories
Ningbo Taikang Chemical
Hangzhou J&H Chemical
Advanced Technology & Industrial
GlaxoSmithKline
Bayer
Novartis
Pfizer
Hoffmann-La Roche
Cipla
Mylan
Ipca Laboratories

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity 98%
Purity 99%
Others

Segment by Application

Chemical Industry
Pharmaceutical Industry

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Mefloquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Mefloquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Mefloquine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Mefloquine Product Introduction

1.2 Global Mefloquine Market Size Forecast

1.2.1 Global Mefloquine Sales Value (2020-2031)

1.2.2 Global Mefloquine Sales Volume (2020-2031)

1.2.3 Global Mefloquine Sales Price (2020-2031)

1.3 Mefloquine Market Trends & Drivers

1.3.1 Mefloquine Industry Trends

1.3.2 Mefloquine Market Drivers & Opportunity

1.3.3 Mefloquine Market Challenges

1.3.4 Mefloquine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Mefloquine Players Revenue Ranking (2024)

2.2 Global Mefloquine Revenue by Company (2020-2025)

2.3 Global Mefloquine Players Sales Volume Ranking (2024)

2.4 Global Mefloquine Sales Volume by Company Players (2020-2025)

2.5 Global Mefloquine Average Price by Company (2020-2025)

2.6 Key Manufacturers Mefloquine Manufacturing Base and Headquarters

2.7 Key Manufacturers Mefloquine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Mefloquine

2.9 Mefloquine Market Competitive Analysis

2.9.1 Mefloquine Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Mefloquine Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefloquine as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Purity 98%

3.1.2 Purity 99%

3.1.3 Others

3.2 Global Mefloquine Sales Value by Type

3.2.1 Global Mefloquine Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Mefloquine Sales Value, by Type (2020-2031)

3.2.3 Global Mefloquine Sales Value, by Type (%) (2020-2031)

3.3 Global Mefloquine Sales Volume by Type

3.3.1 Global Mefloquine Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Mefloquine Sales Volume, by Type (2020-2031)

3.3.3 Global Mefloquine Sales Volume, by Type (%) (2020-2031)

3.4 Global Mefloquine Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Chemical Industry

4.1.2 Pharmaceutical Industry

4.2 Global Mefloquine Sales Value by Application

4.2.1 Global Mefloquine Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Mefloquine Sales Value, by Application (2020-2031)

4.2.3 Global Mefloquine Sales Value, by Application (%) (2020-2031)

4.3 Global Mefloquine Sales Volume by Application

4.3.1 Global Mefloquine Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Mefloquine Sales Volume, by Application (2020-2031)

4.3.3 Global Mefloquine Sales Volume, by Application (%) (2020-2031)

4.4 Global Mefloquine Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Mefloquine Sales Value by Region

5.1.1 Global Mefloquine Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Mefloquine Sales Value by Region (2020-2025)

5.1.3 Global Mefloquine Sales Value by Region (2026-2031)

5.1.4 Global Mefloquine Sales Value by Region (%), (2020-2031)

5.2 Global Mefloquine Sales Volume by Region

5.2.1 Global Mefloquine Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Mefloquine Sales Volume by Region (2020-2025)

5.2.3 Global Mefloquine Sales Volume by Region (2026-2031)

5.2.4 Global Mefloquine Sales Volume by Region (%), (2020-2031)

5.3 Global Mefloquine Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Mefloquine Sales Value, 2020-2031

5.4.2 North America Mefloquine Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Mefloquine Sales Value, 2020-2031

5.5.2 Europe Mefloquine Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Mefloquine Sales Value, 2020-2031

5.6.2 Asia Pacific Mefloquine Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Mefloquine Sales Value, 2020-2031

5.7.2 South America Mefloquine Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Mefloquine Sales Value, 2020-2031

5.8.2 Middle East & Africa Mefloquine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Mefloquine Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Mefloquine Sales Value and Sales Volume

6.2.1 Key Countries/Regions Mefloquine Sales Value, 2020-2031

6.2.2 Key Countries/Regions Mefloquine Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Mefloquine Sales Value, 2020-2031

6.3.2 United States Mefloquine Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Mefloquine Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Mefloquine Sales Value, 2020-2031

6.4.2 Europe Mefloquine Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Mefloquine Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Mefloquine Sales Value, 2020-2031

6.5.2 China Mefloquine Sales Value by Type (%), 2024 VS 2031

6.5.3 China Mefloquine Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Mefloquine Sales Value, 2020-2031

6.6.2 Japan Mefloquine Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Mefloquine Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Mefloquine Sales Value, 2020-2031

6.7.2 South Korea Mefloquine Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Mefloquine Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Mefloquine Sales Value, 2020-2031

6.8.2 Southeast Asia Mefloquine Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Mefloquine Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Mefloquine Sales Value, 2020-2031

6.9.2 India Mefloquine Sales Value by Type (%), 2024 VS 2031

6.9.3 India Mefloquine Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Toronto Research Chemicals

7.1.1 Toronto Research Chemicals Company Information

7.1.2 Toronto Research Chemicals Introduction and Business Overview

7.1.3 Toronto Research Chemicals Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Toronto Research Chemicals Mefloquine Product Offerings

7.1.5 Toronto Research Chemicals Recent Development

7.2 Alfa Chemistry

7.2.1 Alfa Chemistry Company Information

7.2.2 Alfa Chemistry Introduction and Business Overview

7.2.3 Alfa Chemistry Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Alfa Chemistry Mefloquine Product Offerings

7.2.5 Alfa Chemistry Recent Development

7.3 Waterstone Technology

7.3.1 Waterstone Technology Company Information

7.3.2 Waterstone Technology Introduction and Business Overview

7.3.3 Waterstone Technology Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Waterstone Technology Mefloquine Product Offerings

7.3.5 Waterstone Technology Recent Development

7.4 2A PharmaChem

7.4.1 2A PharmaChem Company Information

7.4.2 2A PharmaChem Introduction and Business Overview

7.4.3 2A PharmaChem Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 2A PharmaChem Mefloquine Product Offerings

7.4.5 2A PharmaChem Recent Development

7.5 3B Scientific

7.5.1 3B Scientific Company Information

7.5.2 3B Scientific Introduction and Business Overview

7.5.3 3B Scientific Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 3B Scientific Mefloquine Product Offerings

7.5.5 3B Scientific Recent Development

7.6 Chembest Research Laboratories

7.6.1 Chembest Research Laboratories Company Information

7.6.2 Chembest Research Laboratories Introduction and Business Overview

7.6.3 Chembest Research Laboratories Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Chembest Research Laboratories Mefloquine Product Offerings

7.6.5 Chembest Research Laboratories Recent Development

7.7 Ningbo Taikang Chemical

7.7.1 Ningbo Taikang Chemical Company Information

7.7.2 Ningbo Taikang Chemical Introduction and Business Overview

7.7.3 Ningbo Taikang Chemical Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Ningbo Taikang Chemical Mefloquine Product Offerings

7.7.5 Ningbo Taikang Chemical Recent Development

7.8 Hangzhou J&H Chemical

7.8.1 Hangzhou J&H Chemical Company Information

7.8.2 Hangzhou J&H Chemical Introduction and Business Overview

7.8.3 Hangzhou J&H Chemical Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Hangzhou J&H Chemical Mefloquine Product Offerings

7.8.5 Hangzhou J&H Chemical Recent Development

7.9 Advanced Technology & Industrial

7.9.1 Advanced Technology & Industrial Company Information

7.9.2 Advanced Technology & Industrial Introduction and Business Overview

7.9.3 Advanced Technology & Industrial Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Advanced Technology & Industrial Mefloquine Product Offerings

7.9.5 Advanced Technology & Industrial Recent Development

7.10 GlaxoSmithKline

7.10.1 GlaxoSmithKline Company Information

7.10.2 GlaxoSmithKline Introduction and Business Overview

7.10.3 GlaxoSmithKline Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 GlaxoSmithKline Mefloquine Product Offerings

7.10.5 GlaxoSmithKline Recent Development

7.11 Bayer

7.11.1 Bayer Company Information

7.11.2 Bayer Introduction and Business Overview

7.11.3 Bayer Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Bayer Mefloquine Product Offerings

7.11.5 Bayer Recent Development

7.12 Novartis

7.12.1 Novartis Company Information

7.12.2 Novartis Introduction and Business Overview

7.12.3 Novartis Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Novartis Mefloquine Product Offerings

7.12.5 Novartis Recent Development

7.13 Pfizer

7.13.1 Pfizer Company Information

7.13.2 Pfizer Introduction and Business Overview

7.13.3 Pfizer Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Pfizer Mefloquine Product Offerings

7.13.5 Pfizer Recent Development

7.14 Hoffmann-La Roche

7.14.1 Hoffmann-La Roche Company Information

7.14.2 Hoffmann-La Roche Introduction and Business Overview

7.14.3 Hoffmann-La Roche Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Hoffmann-La Roche Mefloquine Product Offerings

7.14.5 Hoffmann-La Roche Recent Development

7.15 Cipla

7.15.1 Cipla Company Information

7.15.2 Cipla Introduction and Business Overview

7.15.3 Cipla Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Cipla Mefloquine Product Offerings

7.15.5 Cipla Recent Development

7.16 Mylan

7.16.1 Mylan Company Information

7.16.2 Mylan Introduction and Business Overview

7.16.3 Mylan Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Mylan Mefloquine Product Offerings

7.16.5 Mylan Recent Development

7.17 Ipca Laboratories

7.17.1 Ipca Laboratories Company Information

7.17.2 Ipca Laboratories Introduction and Business Overview

7.17.3 Ipca Laboratories Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Ipca Laboratories Mefloquine Product Offerings

7.17.5 Ipca Laboratories Recent Development

8 Industry Chain Analysis

8.1 Mefloquine Industrial Chain

8.2 Mefloquine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Mefloquine Sales Model

8.5.2 Sales Channel

8.5.3 Mefloquine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Mefloquine Market Trends

Table 2. Mefloquine Market Drivers & Opportunity

Table 3. Mefloquine Market Challenges

Table 4. Mefloquine Market Restraints

Table 5. Global Mefloquine Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Mefloquine Revenue Market Share by Company (2020-2025)

Table 7. Global Mefloquine Sales Volume by Company (2020-2025) & (K MT)

Table 8. Global Mefloquine Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Mefloquine Price by Company (2020-2025) & (USD/MT)

Table 10. Key Manufacturers Mefloquine Manufacturing Base and Headquarters

Table 11. Key Manufacturers Mefloquine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Mefloquine

Table 13. Global Mefloquine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefloquine as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Mefloquine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Mefloquine Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Mefloquine Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Mefloquine Sales Market Share in Value by Type (2020-2025)

Table 20. Global Mefloquine Sales Market Share in Value by Type (2026-2031)

Table 21. Global Mefloquine Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)

Table 22. Global Mefloquine Sales Volume by Type (2020-2025) & (K MT)

Table 23. Global Mefloquine Sales Volume by Type (2026-2031) & (K MT)

Table 24. Global Mefloquine Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Mefloquine Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Mefloquine Price by Type (2020-2025) & (USD/MT)

Table 27. Global Mefloquine Price by Type (2026-2031) & (USD/MT)

Table 28. Global Mefloquine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Mefloquine Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Mefloquine Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Mefloquine Sales Market Share in Value by Application (2020-2025)

Table 32. Global Mefloquine Sales Market Share in Value by Application (2026-2031)

Table 33. Global Mefloquine Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)

Table 34. Global Mefloquine Sales Volume by Application (2020-2025) & (K MT)

Table 35. Global Mefloquine Sales Volume by Application (2026-2031) & (K MT)

Table 36. Global Mefloquine Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Mefloquine Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Mefloquine Price by Application (2020-2025) & (USD/MT)

Table 39. Global Mefloquine Price by Application (2026-2031) & (USD/MT)

Table 40. Global Mefloquine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Mefloquine Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Mefloquine Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Mefloquine Sales Value by Region (2020-2025) & (%)

Table 44. Global Mefloquine Sales Value by Region (2026-2031) & (%)

Table 45. Global Mefloquine Sales Volume by Region (K MT): 2020 VS 2024 VS 2031

Table 46. Global Mefloquine Sales Volume by Region (2020-2025) & (K MT)

Table 47. Global Mefloquine Sales Volume by Region (2026-2031) & (K MT)

Table 48. Global Mefloquine Sales Volume by Region (2020-2025) & (%)

Table 49. Global Mefloquine Sales Volume by Region (2026-2031) & (%)

Table 50. Global Mefloquine Average Price by Region (2020-2025) & (USD/MT)

Table 51. Global Mefloquine Average Price by Region (2026-2031) & (USD/MT)

Table 52. Key Countries/Regions Mefloquine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Mefloquine Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Mefloquine Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Mefloquine Sales Volume, (2020-2025) & (K MT)

Table 56. Key Countries/Regions Mefloquine Sales Volume, (2026-2031) & (K MT)

Table 57. Toronto Research Chemicals Company Information

Table 58. Toronto Research Chemicals Introduction and Business Overview

Table 59. Toronto Research Chemicals Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 60. Toronto Research Chemicals Mefloquine Product Offerings

Table 61. Toronto Research Chemicals Recent Development

Table 62. Alfa Chemistry Company Information

Table 63. Alfa Chemistry Introduction and Business Overview

Table 64. Alfa Chemistry Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 65. Alfa Chemistry Mefloquine Product Offerings

Table 66. Alfa Chemistry Recent Development

Table 67. Waterstone Technology Company Information

Table 68. Waterstone Technology Introduction and Business Overview

Table 69. Waterstone Technology Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 70. Waterstone Technology Mefloquine Product Offerings

Table 71. Waterstone Technology Recent Development

Table 72. 2A PharmaChem Company Information

Table 73. 2A PharmaChem Introduction and Business Overview

Table 74. 2A PharmaChem Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 75. 2A PharmaChem Mefloquine Product Offerings

Table 76. 2A PharmaChem Recent Development

Table 77. 3B Scientific Company Information

Table 78. 3B Scientific Introduction and Business Overview

Table 79. 3B Scientific Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 80. 3B Scientific Mefloquine Product Offerings

Table 81. 3B Scientific Recent Development

Table 82. Chembest Research Laboratories Company Information

Table 83. Chembest Research Laboratories Introduction and Business Overview

Table 84. Chembest Research Laboratories Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 85. Chembest Research Laboratories Mefloquine Product Offerings

Table 86. Chembest Research Laboratories Recent Development

Table 87. Ningbo Taikang Chemical Company Information

Table 88. Ningbo Taikang Chemical Introduction and Business Overview

Table 89. Ningbo Taikang Chemical Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 90. Ningbo Taikang Chemical Mefloquine Product Offerings

Table 91. Ningbo Taikang Chemical Recent Development

Table 92. Hangzhou J&H Chemical Company Information

Table 93. Hangzhou J&H Chemical Introduction and Business Overview

Table 94. Hangzhou J&H Chemical Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 95. Hangzhou J&H Chemical Mefloquine Product Offerings

Table 96. Hangzhou J&H Chemical Recent Development

Table 97. Advanced Technology & Industrial Company Information

Table 98. Advanced Technology & Industrial Introduction and Business Overview

Table 99. Advanced Technology & Industrial Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 100. Advanced Technology & Industrial Mefloquine Product Offerings

Table 101. Advanced Technology & Industrial Recent Development

Table 102. GlaxoSmithKline Company Information

Table 103. GlaxoSmithKline Introduction and Business Overview

Table 104. GlaxoSmithKline Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 105. GlaxoSmithKline Mefloquine Product Offerings

Table 106. GlaxoSmithKline Recent Development

Table 107. Bayer Company Information

Table 108. Bayer Introduction and Business Overview

Table 109. Bayer Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 110. Bayer Mefloquine Product Offerings

Table 111. Bayer Recent Development

Table 112. Novartis Company Information

Table 113. Novartis Introduction and Business Overview

Table 114. Novartis Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 115. Novartis Mefloquine Product Offerings

Table 116. Novartis Recent Development

Table 117. Pfizer Company Information

Table 118. Pfizer Introduction and Business Overview

Table 119. Pfizer Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 120. Pfizer Mefloquine Product Offerings

Table 121. Pfizer Recent Development

Table 122. Hoffmann-La Roche Company Information

Table 123. Hoffmann-La Roche Introduction and Business Overview

Table 124. Hoffmann-La Roche Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 125. Hoffmann-La Roche Mefloquine Product Offerings

Table 126. Hoffmann-La Roche Recent Development

Table 127. Cipla Company Information

Table 128. Cipla Introduction and Business Overview

Table 129. Cipla Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 130. Cipla Mefloquine Product Offerings

Table 131. Cipla Recent Development

Table 132. Mylan Company Information

Table 133. Mylan Introduction and Business Overview

Table 134. Mylan Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 135. Mylan Mefloquine Product Offerings

Table 136. Mylan Recent Development

Table 137. Ipca Laboratories Company Information

Table 138. Ipca Laboratories Introduction and Business Overview

Table 139. Ipca Laboratories Mefloquine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 140. Ipca Laboratories Mefloquine Product Offerings

Table 141. Ipca Laboratories Recent Development

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Mefloquine Downstream Customers

Table 145. Mefloquine Distributors List

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Mefloquine Product Picture

Figure 2. Global Mefloquine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Mefloquine Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Mefloquine Sales Volume (2020-2031) & (K MT)

Figure 5. Global Mefloquine Sales Price (2020-2031) & (USD/MT)

Figure 6. Mefloquine Report Years Considered

Figure 7. Global Mefloquine Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Mefloquine Players Sales Volume Ranking (2024) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mefloquine Revenue in 2024

Figure 10. Mefloquine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Purity 98% Picture

Figure 12. Purity 99% Picture

Figure 13. Others Picture

Figure 14. Global Mefloquine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Mefloquine Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Mefloquine Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)

Figure 17. Global Mefloquine Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Mefloquine Price by Type (2020-2031) & (USD/MT)

Figure 19. Product Picture of Chemical Industry

Figure 20. Product Picture of Pharmaceutical Industry

Figure 21. Global Mefloquine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Mefloquine Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Mefloquine Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)

Figure 24. Global Mefloquine Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Mefloquine Price by Application (2020-2031) & (USD/MT)

Figure 26. North America Mefloquine Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Mefloquine Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Mefloquine Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Mefloquine Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Mefloquine Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Mefloquine Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Mefloquine Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Mefloquine Sales Volume (%), (2020-2031)

Figure 38. United States Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 44. China Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 46. China Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 56. India Mefloquine Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Mefloquine Sales Value by Type (%), 2024 VS 2031

Figure 58. India Mefloquine Sales Value by Application (%), 2024 VS 2031

Figure 59. Mefloquine Industrial Chain

Figure 60. Mefloquine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Mefloquine market? zhanKai

The top companies in the global Mefloquine market are Toronto Research Chemicals、Alfa Chemistry、Waterstone Technology.

Related Reports

Global Mefloquine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mefloquine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 105
USD 4250.00
(Single User License)
Global Mefloquine Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mefloquine market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 178
USD 4900.00
(Single User License)
Mefloquine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mefloquine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 143
USD 3950.00
(Single User License)
Global Mefloquine Market Research Report 2026
The global Mefloquine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 148
USD 2900.00
(Single User License)
Global Mefloquine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mefloquine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
Global Mefloquine Market Insights, Forecast to 2031
The global Mefloquine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2025-05-25
Pages: 175
USD 4900.00
(Single User License)
Global Mefloquine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mefloquine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-05-25
Pages: 106
USD 4250.00
(Single User License)
Global Mefloquine Market Research Report 2025
The global market for Mefloquine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-05-25
Pages: 110
USD 2900.00
(Single User License)
Mefloquine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mefloquine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 107
USD 3950.00
(Single User License)
Global Mefloquine Market Insights, Forecast to 2030
Mefloquine (CAS 53230-10-7)
Published Date: 2024-04-15
Pages: 105
USD 4900.00
(Single User License)

Global Mefloquine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mefloquine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 105
USD 4250.00 (Single User License)
Global Mefloquine Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mefloquine market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 178
USD 4900.00 (Single User License)
Mefloquine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mefloquine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 143
USD 3950.00 (Single User License)
Global Mefloquine Market Research Report 2026
The global Mefloquine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 148
USD 2900.00 (Single User License)
Global Mefloquine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mefloquine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
USD 4900.00 (Single User License)
Global Mefloquine Market Insights, Forecast to 2031
The global Mefloquine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2025-05-25
Pages: 175
USD 4900.00 (Single User License)
Global Mefloquine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mefloquine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-05-25
Pages: 106
USD 4250.00 (Single User License)
Global Mefloquine Market Research Report 2025
The global market for Mefloquine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-05-25
Pages: 110
USD 2900.00 (Single User License)
Mefloquine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mefloquine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 107
USD 3950.00 (Single User License)
Global Mefloquine Market Insights, Forecast to 2030
Mefloquine (CAS 53230-10-7)
Published: 2024-04-15
Pages: 105
USD 4900.00 (Single User License)